August 6, 2021
August 6, 2021 – KVK Tech, Inc., has voluntarily recalled two lots of Atovaquone Oral Suspension, USP 750
mg/5mL, following customer complaints that the product was unusually gritty
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
August 2, 2021
August 2, 2021 – The U.S. FDA has approved SaphneloTM (anifrolumab-fnia), manufactured by AstraZeneca,
to treat moderate to severe systemic lupus erythematosus (SLE) in adults who
July 30, 2021
July 29, 2021
July 29, 2021 – The U.S. FDA has approved changes to the Risk Evaluation and Mitigation Strategy (REMS)
program
July 29, 2021
July 29, 2021 – Nucala® (mepolizumab), manufactured by GlaxoSmithKline, has received U.S. FDA approval for a new indication to treat chronic rhinosinusitis with nasal polyps (CRSwNP)
July 28, 2021
July 28, 2021 – Pepaxto® (melphalan flufenamide – Oncopeptides AB) may increase the risk of death for patients who have multiple myeloma, according to the U.S. FDA. In 2021
July 28, 2021
July 28, 2021 – The U.S. FDA has expanded the scope of Emergency Use Authorization (EUA) for Olumiant
(baricitinib – Eli Lilly) to allow
July 28, 2021
July 28, 2021 – Mylan’s Semglee® (insulin glargine-yfgn) injection has been FDA approved as the first
automatically interchangeable insulin and the first automatically interchangeable biosimilar